Internal Medicine, Hematology & Oncology · Norton Shores, MI
NPI
1578084232
Since 2017
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6425 Harvey St
Norton Shores, MI, 49444
Phone (231) 737-3469
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
72,886 services
Medicare patients, 2024
248
Average age 72
Drug cost, 2024
$1.5M
1,051 prescriptions
Company payments, 2025
$7,934
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zabila Saeed was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 1,842 times for 48 patients. In total Zabila Saeed billed 72,886 services in 163 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,842 | 48 | $0.09 | $164 |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 1,680 | 12 | $0.06 | $108 |
| J9190 Injection, fluorouracil, 500 mg | Office | 988 | 20 | $2.32 | $2,294 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 970 | 28 | $0.72 | $703 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 639 | 11 | $3.51 | $2,243 |
| J9206 Injection, irinotecan, 20 mg | Office | 629 | 12 | $2.02 | $1,272 |
| 36415 Venipuncture Blood Collection | Office | 484 | 85 | $8.54 | $4,132 |
| 85025 Blood Count | Office | 446 | 81 | $7.51 | $3,351 |
| 80053 Clinical Chemistry | Office | 424 | 83 | $10.26 | $4,352 |
| J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Office | 378 | 12 | $2.53 | $956 |
| 96375 Injection Administration | Office | 345 | 60 | $11.25 | $3,880 |
| 99214 Office E&M - Established | Office | 255 | 101 | $97.08 | $25K |
| 96413 Chemotherapy Administration | Office | 209 | 62 | $96.77 | $20K |
| 83735 Clinical Chemistry | Office | 113 | 26 | $6.42 | $726 |
| 96372 Injection Administration | Office | 112 | 32 | $11.03 | $1,236 |
By year: 2022 $2,997 for 52 services; 2023 $11K for 732 services; 2024 $1.2M for 72,886 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 484 | 85 | $8.54 | $4,132 |
| 85025 Blood Count | 446 | 81 | $7.51 | $3,351 |
| 80053 Clinical Chemistry | 424 | 83 | $10.26 | $4,352 |
| 83735 Clinical Chemistry | 113 | 26 | $6.42 | $726 |
| 86301 Immunoassay | 69 | 17 | $20.39 | $1,407 |
| 82378 Clinical Chemistry | 64 | 31 | $18.33 | $1,173 |
| 86704 Immunoassay | 20 | 20 | $11.31 | $226 |
| 86706 Immunoassay | 20 | 20 | $10.08 | $202 |
| 87340 Immunoassay | 20 | 20 | $9.69 | $194 |
Medicare prescription drug claims, 2024
In 2024, the drug Zabila Saeed prescribed most often to Medicare patients was Prochlorperazine Maleate, with 104 prescriptions and refills. In total Zabila Saeed wrote 1,051 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 104 | 104 | 69 | $1,291 |
| Potassium Chloride Generic | 77 | 81 | 29 | $543 |
| Prednisone Generic | 48 | 48 | 27 | $138 |
| Ondansetron Odt Ondansetron | 47 | 47 | 35 | $613 |
| Imatinib Mesylate Generic | 44 | 45 | Under 11 | $27K |
| Eliquis Apixaban | 42 | 50 | 16 | $27K |
| Furosemide Generic | 41 | 53 | 22 | $109 |
| Olanzapine Generic | 38 | 38 | 21 | $236 |
| Creon Lipase/Protease/Amylase | 33 | 38 | 13 | $45K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 28 | 28 | 23 | $294 |
| Gabapentin Generic | 26 | 28 | 14 | $136 |
| Pantoprazole Sodium Generic | 25 | 31 | Under 11 | $188 |
| Nyvepria Pegfilgrastim-Apgf | 22 | 22 | Under 11 | $135K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 19 | 21 | Under 11 | $29.37 |
| Lonsurf Trifluridine/Tipiracil Hcl | 19 | 19 | Under 11 | $289K |
Brand drugs: - claims; generic drugs: 834 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zabila Saeed $7,934 ($7,934 in general payments such as food, travel and fees) from 31 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $5,963.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $5,963 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $237 |
| Eisai Inc. 4523.T | 8 | $226 |
| Merck Sharp & Dohme LLC MRK | 5 | $145 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $114 |
| Janssen Biotech, Inc. JNJ | 5 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $101 |
| Telix Pharmaceuticals TLX | 1 | $100 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $85.17 |
| Geron Corporation GERN | 3 | $83.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.